MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $849,000 | +84.6% | 25,531 | +50.8% | 0.00% | 0.0% |
| Q1 2020 | $460,000 | +189.3% | 16,929 | +38.3% | 0.00% | – |
| Q3 2019 | $159,000 | +4.6% | 12,240 | 0.0% | 0.00% | – |
| Q2 2019 | $152,000 | -20.8% | 12,240 | -7.6% | 0.00% | – |
| Q1 2019 | $192,000 | +9.7% | 13,240 | -16.5% | 0.00% | – |
| Q4 2018 | $175,000 | -65.9% | 15,860 | -18.7% | 0.00% | -100.0% |
| Q3 2018 | $513,000 | +48.3% | 19,516 | +15.4% | 0.00% | 0.0% |
| Q2 2018 | $346,000 | +12.7% | 16,917 | +0.0% | 0.00% | 0.0% |
| Q1 2018 | $307,000 | +37.1% | 16,909 | +5.1% | 0.00% | – |
| Q4 2017 | $224,000 | -24.1% | 16,086 | +0.7% | 0.00% | -100.0% |
| Q3 2017 | $295,000 | +5.4% | 15,971 | -3.6% | 0.00% | 0.0% |
| Q2 2017 | $280,000 | +25.6% | 16,575 | -0.9% | 0.00% | 0.0% |
| Q1 2017 | $223,000 | -7.5% | 16,720 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $241,000 | +28.2% | 16,026 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $188,000 | – | 16,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |